CIK 0001847367 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,214,582 shares (grant or award)
- 4 Grant or award Director acquired 4,493,741 shares (grant or award)
- 4 Grant or award Director acquired 7,064 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 45,000 shares at an average $4.50 ($202,300)
- 4 Open-market buy 10% owner bought 45,000 shares at an average $4.50 ($202,300)
- 4 Open-market buy 10% owner bought 45,000 shares at an average $4.50 ($202,300)
- 4 Open-market buy Director bought 320,290 shares at an average $4.61 ($1,477,312)
- 4 Open-market buy Director bought 18,404 shares at an average $7.04 ($129,544)
- 4 Open-market buy President, CEO and Chairman bought 15,650 shares at $6.44 ($100,733)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 6 · 114 filings